Keywords: hmr, gets, priority, review, ra, drug, hoechst

HMR Gets Priority Review For RA Drug

Article | 14 May 1998

Print This

Hoechst Marion Roussel has been granted priority review by the US Foodand Drug Administration for Arava (leflunomide), its treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in